Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Hepatology

• Publication date

  2010-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.23273PMID 19842207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection

  2009cited by this paper
• The interleukin‐17 pathway is involved in human alcoholic liver disease

  2009cited by this paper
• Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.

  2009cited by this paper
• A novel IL‐17‐dependent mechanism of cross protection: Respiratory infection with mycoplasma protects against a secondary listeria infection

  2009cited by this paper
• Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells.

  2008cited by this paper
• Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.

  2008cited by this paper
• Hepatitis C Virus-Specific Th17 Cells Are Suppressed by Virus-Induced TGF-β1

  2008cited by this paper
• Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure.

  2008cited by this paper
• Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.

  2008cited by this paper
• Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta.

  2008cited by this paper
• Emergence of the Th17 pathway and its role in host defense.

  2008cited by this paper
• Cutting Edge: Programmed Death-1 Up-Regulation Is Involved in the Attrition of Cytomegalovirus-Specific CD8+ T Cells in Acute Self-Limited Hepatitis B Virus Infection1

  2008cited by this paper
• Requirement of IL-17RA in Con A Induced Hepatitis and Negative Regulation of IL-17 Production in Mouse T Cells

  2008cited by this paper
• Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage

  2007cited by this paper
• Chronic Hepatitis B

  2007cited by this paper
• Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection.

  2007cited by this paper
• PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors.

  2007cited by this paper
• Interleukin‐17 as a new marker of severity of acute hepatic injury

  2007cited by this paper
• Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B.

  2007cited by this paper
• IL-17 family cytokines and the expanding diversity of effector T cell lineages.

  2007cited by this paper
• Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation.

  2007cited by this paper
• Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.

  2007cited by this paper
• Corrections to AASLD guidelines on chronic hepatitis B

  2007cited by this paper
• Innate immune response and hepatic inflammation.

  2007cited by this paper
• Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges

  2007cited by this paper
• Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B1

  2006cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• Immunology of hepatitis B virus and hepatitis C virus infection

  2005cited by this paper
• Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels.

  2005cited by this paper
• MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs.

  2004cited by this paper
• Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5.

  2004cited by this paper
• Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells.

  2004cited by this paper
• Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation

  2004cited by this paper
• Translation of immunological knowledge into better treatments of chronic hepatitis B.

  2003cited by this paper
• IL-17 Expression in Human Herpetic Stromal Keratitis: Modulatory Effects on Chemokine Production by Corneal Fibroblasts1

  2002cited by this paper
• Chronic hepatitis B

  2001cited by this paper
• Noncytolytic control of viral infections by the innate and adaptive immune response.

  2001cited by this paper
• The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

  2000cited by this paper
• The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection

  2000cited by this paper
• Classification of chronic viral hepatitis: a need for reassessment.

  1991cited by this paper

• Proliferation, migration, and differentiation of circulating ILC precursors in HBV infection-associated fibrosis

  2026cites this paper
• IL-21 attenuates liver inflammation by enhancing myeloid-derived suppressor cells immunosuppressive function in chronic HBV infection

  2025cites this paper
• Concanavalin‐A‐Induced Acute Liver Injury in Mice

  2024cites this paper
• Interleukin-17A (IL-17A) is involved in antibody specificity to conformational epitopes.

  2024cites this paper
• Mechanisms of Inflammasome Activation and Involvement in Liver Disease

  2024cites this paper
• Current research insights into the role of CTLA‐4 in hepatitis B virus (HBV) infection

  2024cites this paper
• Macrophage Evolution during Progression of Hepatitis Virus B-Related Acute-on-Chronic Liver Failure

  2024cites this paper
• Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease

  2024cites this paper
• SPP1 as a risk factor for patients with acute on chronic liver failure undergoing liver transplantation.

  2023cites this paper
• The Role of Interleukins in HBV Infection: A Narrative Review

  2023cites this paper
• CHINAT-CD4 Score Predicts Transplant-Free Survival in Patients with Acute-on-Chronic Liver Failure

  2023cites this paper
• Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy.

  2023cites this paper
• Current perspective on biological properties of plasmacytoid dendritic cells and dysfunction in gut

  2023cites this paper
• Relationship between IL-17, TNF-α, IL-10, IFN-γ, and IL-18 polymorphisms with the outcome of hepatitis B virus infection in the Turkish population

  2023cites this paper
• Regulation of systemic metabolism by tissue-resident immune cell circuits.

  2023cites this paper
• Expression Level of Inflammation-Related Cytokines in the Progression of Chronic Hepatitis B and Their Correlation with Clinical Indexes

  2023cites this paper
• m6A Regulator-mediated RNA Methylation Modulates Immune Microenvironment of Hepatitis B Virus-related Acute Liver Failure

  2023cites this paper
• Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients

  2023cites this paper
• Research Progress of Blood-Derived Biomarkers Predicting Prognosis of Liver Cirrhosis

  2023cites this paper
• HMGB1/PTEN/PI3K axis participates in the peripheral immune cell differentiation in two representative TCM syndromes of chronic hepatitis B patients

  2022cites this paper
• Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients

  2022cites this paper
• Clinical Significance and Properties of IFN-γ+IL-17+ Th17 Cells in Liver Injury Associated with Chronic Hepatitis B Virus Infection

  2022cites this paper
• The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs.

  2022cites this paper
• Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice.

  2022cites this paper
• Circulating IL-1β, IL-17, and IP-10 as Potential Predictors of Hepatitis B Virus Infection Prognosis

  2022cites this paper
• Current Advances of Innate and Adaptive Immunity in Acute-on-Chronic Hepatitis B Liver Failure

  2022cites this paper
• Th17 cells in the liver: balancing autoimmunity and pathogen defense

  2022cites this paper
• Vitamin D role in hepatitis B: focus on immune system and genetics mechanism

  2022cites this paper
• Mesenchymal stem cells-based therapy in liver diseases

  2022cites this paper
• Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure

  2022cites this paper
• Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells

  2022cites this paper
• Murine cytomegalovirus promotes renal allograft inflammation via Th1/17 cells and IL‐17A

  2022cites this paper
• Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis

  2021cites this paper
• Characteristics of Circulatory γδ T cells in Patients with Symptomatic Chronic Hepatitis B Infection

  2021cites this paper
• CD4+ T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy

  2021cites this paper
• Interleukin-17 in Liver Disease Pathogenesis

  2021cites this paper
• Role of CD4+ T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

  2021cites this paper
• Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

  2021cites this paper
• Increased Circulating T Follicular Helper Cells Induced via IL-12/21 in Patients With Acute on Chronic Hepatitis B Liver Failure

  2021cites this paper
• Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

  2021cites this paper
• Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF

  2021cites this paper
• KRONİK HEPATİT B HASTALARINDA SERUM IL-17 DÜZEYLERİNİN DEĞERLENDİRİLMESİ

  2021cites this paper
• Based on HMGB1-PTEN pathway to explore the difference of T lymphocyte function in chronic hepatitis B with representative TCM syndromes

  2021cites this paper
• ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis

  2021cites this paper
• Diverse Functions of γδ T Cells in the Progression of Hepatitis B Virus and Hepatitis C Virus Infection

  2021cites this paper
• Dendritic Cells and T Cell Subsets in the Development of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

  2021cites this paper
• Dynamics of Immune Activation in Viral Diseases

  2020cites this paper
• The Impaired Balance of CD4+/CD8+ Ratio in Patients with Chronic Hepatitis B

  2020cites this paper
• Serum Interleukin-35 Level in Correlation with T Regulatory and T helper-17 Cells Frequency in Chronic Viral Hepatitis C Patients

  2020cites this paper
• Nanoparticles (PLGA and Chitosan)-Entrapped ADP-Ribosylation Factor 1 of Haemonchus contortus Enhances the Immune Responses in ICR Mice

  2020cites this paper
• Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients

  2020cites this paper
• Cytokine, Genotype, and Viral Load Profile in the Acute and Chronic Hepatitis B

  2020cites this paper
• A Comparative Study of Different Joint Modeling Approaches for HIV/AIDS Patients in Southern Iran

  2020cites this paper
• Research on the Pathogenesis of Chronic Hepatitis B: From T lymphocyte to HMGB1-PTEN Pathway

  2020cites this paper
• Characterization of the IL-17 and CD4+ Th17 Cells in the Clinical Course of Dengue Virus Infections

  2020cites this paper
• HBV promotes the recruitment of IL‐17 secreting T cells via chemokines CCL22 and CCL17

  2020cites this paper
• Role of Immune Cells in Hepatitis B Infection

  2020cites this paper
• Intrahepatic T helper 17 cells recruited by hepatitis B virus X antigen‐activated hepatic stellate cells exacerbate the progression of chronic hepatitis B virus infection

  2020cites this paper
• The serum interleukin-26 level is a potential biomarker for chronical hepatitis B

  2020cites this paper
• Immunopathobiology and therapeutic targets related to cytokines in liver diseases

  2020cites this paper
• Cytokine Pro le During Occult Hepatitis B Virus Infection in Chronic Hepatitis C Patients

  2020cites this paper
• Activated γδ T cells exhibit cytotoxicity and the capacity for viral clearance in patients with acute hepatitis B.

  2019cites this paper
• Impaired circulating CD56dim NK cells are associated with decompensation of HBV-related cirrhosis.

  2019cites this paper
• Levels of human cytomegalovirus miR-US25-1-5p and miR-UL112-3p in serum extracellular vesicles from infants with HCMV active infection are significantly correlated with liver damage

  2019cites this paper
• Elevated interleukin‐35 suppresses liver inflammation by regulation of T helper 17 cells in acute hepatitis B virus infection

  2019cites this paper
• CD4 T cells in hepatitis B virus: "You don't have to be cytotoxic to work here and help".

  2019cites this paper
• Tim‐3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B

  2019cites this paper
• Establishment of an analysis model based on measurement of hepatitis B viral infection serum markers

  2019cites this paper
• Dual effect of T helper cell 17 (Th17) and regulatory T cell (Treg) in liver pathological process: From occurrence to end stage of disease.

  2019cites this paper
• Immune Cell Trafficking to the Liver.

  2019cites this paper
• Exploration of the Relationship between Interleukins 17, 37 and 38 with Vitamin E in Iraqi Men with CHB.

  2019cites this paper
• Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis

  2019cites this paper
• Evaluation of single nucleotide polymorphism in interleukin 22 (IL-22) gene and its association with chronic hepatitis B infection

  2019cites this paper
• Metabolomics profiling of Polygoni Multiflori Radix and Polygoni Multiflori Radix Preparata extracts using UPLC-Q/TOF-MS

  2019cites this paper
• Hepatitis Arthritis: HBV and HCV

  2019cites this paper
• TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.

  2019cites this paper
• Increased interleukin‐23 receptor (IL‐23R) expression is associated with disease severity in acute‐on‐chronic liver failure

  2019cites this paper
• Increased values of peripheral blood γδT cells , Th 17 cells , IL-17 , ALT , AST , TB , and DB are closely related to the severity of chronic hepatitis B

  2019cites this paper
• Type 3 cytokines in liver fibrosis and liver cancer.

  2019cites this paper
• The Relationship Between Serum IL-17 Level and Viral Load in Chronic Hepatitis B

  2019cites this paper
• IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease.

  2019cites this paper
• Main Complications of AECHB and Severe Hepatitis B (Liver Failure)

  2019cites this paper
• Immunological Features of AECHB

  2019cites this paper
• Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection

  2019cites this paper
• Role of Foxp3/Treg and RORγt/Th17 imbalance in chronic hepatitis B virus infection

  2019cites this paper
• Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV‐relative liver cirrhosis

  2019cites this paper
• TIPE2 as a potential therapeutic target in chronic viral hepatitis

  2019cites this paper
• Autoimmune Hepatitis and Stellate Cells; an Insight into the Role of Autophagy.

  2019cites this paper
• Acute Exacerbation of Chronic Hepatitis B: Volume 1. Definition, Research Technology, Virology, Genetics and Immunology

  2019cites this paper
• Assessment of the role of interleukin 17A and interleukin 17F in chronic hepatitis C virus infection in Egyptian patients

  2019cites this paper
• Distribution of Human Constitutional Types Used In Traditional Mongolian Medicine among Patients with Chronic Hepatitis B

  2018cites this paper
• Expression of interleukin-17 is associated with different immune phases in patients with chronic hepatitis B

  2018cites this paper
• Model for Non-Invasive Diagnosis of NAFLD Incorporating Caspase 3-Cleaved Cytokeratin-18: A Clinical, Serological, and Immunohistochemical Analysis

  2018cites this paper
• WITHDRAWN: IL-22 in liver inflammation, injury and repair

  2018cites this paper
• NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL‐17 and TNF in mice

  2018cites this paper
• Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients

  2018cites this paper
• Type 3 innate lymphoid cell: a new player in liver fibrosis progression.

  2018cites this paper
• BATF Interference Blocks Th17 Cell Differentiation and Inflammatory Response in Hepatitis B Virus Transgenic Mice

  2018cites this paper
• IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases.

  2018cites this paper
• High levels of circulating GM-CSF+CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study

  2018cites this paper